Skip to content

A psychological programme to improve low mood in adolescence

A brief early intervention for adolescent depression that targets emotional memories: a feasibility randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85369879
Enrollment
56
Registered
2017-04-04
Start date
2017-04-10
Completion date
Unknown
Last updated
2023-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders Depression

Interventions

Eligible participants will be randomised by the Kings Clinical Trials Unit (KCTU). Participants will be randomised using block randomisation via a web interface. Randomly varying block sizes will redu

Sponsors

King's College London
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 16-18 2. Informed consent 3. Willing and able to engage in psychological therapy and complete assessments 4. Scoring above clinical cut-off on Mood and Feelings Questionnaire (MFQ clinical cut-off = 20).

Exclusion criteria

Exclusion criteria: 1. Diagnosis of learning disability or significant head injury, neurological disorder or epilepsy 2. Unable to fluently communicate in spoken English 3. Unable to give informed consent 4. Factors contra-indicating imagery rescripting, e.g. high levels of current risk 5. Currently receiving therapy 6. Experiencing psychotic symptoms or depressed in the postnatal period (participants with comorbid physical illness or non-psychotic disorders such as anxiety will not be excluded)

Design outcomes

Primary

MeasureTime frame
Feasibility outcome: Feasibility and acceptability of the intervention is assessed by recording numbers of eligible participants, recruitment rate, retention rate outcome measure completion rate, data completeness, incidence of unexpected adverse events, data on adherence/compliance, and feedback questionnaires.

Secondary

MeasureTime frame
Principal clinical outcome Depression is measured using the Mood and Feelings Questionnaire (MFQ; long version) pre-therapy, post-therapy and 3-month follow-up. (The short version of the MFQ will also be administered at each intervention session.) Other measures 1. Anxiety is measured using the Screen for Child Anxiety Related Disorders pre-therapy, post-therapy and 3-month follow-up 2. Symptoms of post-traumatic stress are measured using the Revised Impact of Event Scale: child version pre-therapy, post-therapy and 3-month follow-up 3. Response style is measured using the Children’s Response Style Questionnaire pre-therapy, post-therapy and 3-month follow-up 4. Self-esteem is measured using the Rosenberg Self-Esteem Scale pre-therapy, post-therapy and 3-month follow-up 5. Self-Concept Clarity is measured using the Self-Concept Clarity scale pre-therapy, post-therapy and 3-month follow-up 6. Mental Imagery for future events is measured using the Prospective Imagery Task pre-therapy, post-therapy and 3-month follow-up 7. Memory specificity is measured using the Autobiographical Memory Task pre-therapy, post-therapy and 3-month follow-up 8. Daily mood is measured for seven days using daily mood ratings pre-therapy and post-therapy 9. Emotional response (subjective ratings and heart rate variability) to autobiographical memories is measured using a positive memory recall task pre-therapy and post-therapy

Countries

England, United Kingdom

Contacts

Public ContactVictoria Pile
victoria.pile@kcl.ac.uk+44 (0)20 7848 0389

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 24, 2026